Biochemical markers in sarcoidosis
- PMID: 3024907
- DOI: 10.3109/10408368609110273
Biochemical markers in sarcoidosis
Abstract
The clinical course of sarcoidosis is varying and unpredictable. Once the diagnosis has been made, the clinician needs simple tests to detect and predict remission or progression, to determine whether treatment is effective or not, and to assess the clinical activity of the disease. Sarcoidosis is a multisystem disease, but the lungs are almost always involved. Traditionally, the clinical management has therefore included chest X-rays and lung function studies. Extrapulmonary lesions have been followed in different ways. Sensitive and reproducible biochemical tests would be helpful in evaluating the clinical course of patients with sarcoidosis, if they measure functions related to the granulomatous inflammation. This review will deal with measurements of serum and urinary calcium, and 1,25-dihydroxyvitamin D. The usefulness of single and serial determinations of lysozyme, angiotensin converting enzyme, beta 2-microglobulin, collagenase, carboxypeptidase and glucuronidase in serum, bronchoalveolar lavage fluid, and other biological fluids will be discussed.
Similar articles
-
[Biological manifestations of sarcoidosis].Ann Med Interne (Paris). 2001 Feb;152(1):34-8. Ann Med Interne (Paris). 2001. PMID: 11240424 Review. French.
-
Bronchioalveolar angiotensin converting enzyme activity. Value in assessing disease activity in sarcoidosis.J Med. 1984;15(3):213-25. J Med. 1984. PMID: 6098625
-
Value of biochemical markers in serum for determination of disease activity in sarcoidosis.Sarcoidosis. 1984 Sep;1(1):45-9. Sarcoidosis. 1984. PMID: 6100924 No abstract available.
-
Relation between clinical stage of sarcoidosis and serum values of angiotensin converting enzyme and beta2-microglobulin.Sarcoidosis. 1987 Mar;4(1):13-7. Sarcoidosis. 1987. PMID: 3035674
-
[Angiotensin I-converting enzyme (ACE) for sarcoidosis diagnosis].Pathol Biol (Paris). 2005 Apr;53(3):183-8. doi: 10.1016/j.patbio.2004.09.003. Pathol Biol (Paris). 2005. PMID: 15781381 Review. French.
Cited by
-
The relationship between erythema nodosum and prognosis in systemic sarcoidosis: a retrospective cohort study.An Bras Dermatol. 2022 Sep-Oct;97(5):606-611. doi: 10.1016/j.abd.2021.09.011. Epub 2022 Jul 7. An Bras Dermatol. 2022. PMID: 35811196 Free PMC article.
-
Subcutaneous sarcoidosis: a clinical analysis of nine patients.Clin Rheumatol. 2016 Sep;35(9):2277-81. doi: 10.1007/s10067-016-3356-0. Epub 2016 Jul 23. Clin Rheumatol. 2016. PMID: 27449952
-
Sarcoidois: is it only a mimicker of primary rheumatic disease? A single center experience.Ther Adv Musculoskelet Dis. 2014 Feb;6(1):3-7. doi: 10.1177/1759720X13511197. Ther Adv Musculoskelet Dis. 2014. PMID: 24489610 Free PMC article.
-
Activation of peripheral blood mononuclear cells in bronchoalveolar lavage fluid from patients with sarcoidosis: visualisation of single cell activation products.Thorax. 1994 Nov;49(11):1146-51. doi: 10.1136/thx.49.11.1146. Thorax. 1994. PMID: 7831632 Free PMC article.
-
Identification of apolipoprotein A-I in BALF as a biomarker of sarcoidosis.Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(1):5-15. doi: 10.36141/svdld.v35i1.5834. Epub 2018 Apr 28. Sarcoidosis Vasc Diffuse Lung Dis. 2018. PMID: 32476874 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials